The genetics align with how people with ME have described their illness
For generations, millions of people living with myalgic encephalomyelitis have carried an invisible illness into a medical world that too often turned them away. Now, the largest genetic study of ME/CFS ever conducted has found eight distinct regions of the human genome that differ meaningfully between those with the condition and those without — evidence that the disease is written into biology, not imagination. The findings, drawn from the DNA of nearly 300,000 people, do not yet offer a cure or a diagnostic test, but they offer something patients have long been denied: the weight of scientific confirmation that their suffering is real.
- An estimated 67 million people worldwide have lived with ME/CFS while medicine debated whether their illness existed at all — a decades-long failure of institutional belief that has left patients isolated, untreated, and economically devastated.
- The DecodeME study, analyzing genetic data from 27,000 patients and over 250,000 healthy controls, has identified eight genomic regions linked to disease risk, implicating immune defense and nervous system function in ways that mirror patients' own descriptions of their condition.
- Despite the breakthrough, critical gaps remain — researchers found no genetic explanation for why women are four times more likely to be diagnosed, and no shared genetic basis was found between ME/CFS and long Covid, despite their overlapping symptoms.
- Parallel brain imaging research at Oxford has detected abnormally high lactate levels in a region of the brain tied to effort and emotion, pointing toward disrupted energy metabolism and possibly malfunctioning mitochondria as another biological thread in the disease.
- The findings have not yet passed peer review and do not yet yield treatments or diagnostic tools, but they are already reshaping the conversation — shifting the burden of proof away from patients and toward the institutions that failed them.
For decades, people with ME/CFS walked into doctors' offices describing crushing fatigue, brain fog, unrefreshing sleep, and a particular cruelty: any exertion — physical or mental — could trigger a collapse lasting weeks. Many were told their illness was psychological. Some were disbelieved entirely. Now, for the first time, geneticists have found robust evidence that the condition is rooted in human biology.
The DecodeME study, a collaboration between Edinburgh University and patient advocacy groups, examined DNA from 27,000 people with ME/CFS and more than 250,000 without it — an unprecedented dataset for a long-neglected disease. Researchers identified eight regions of the genome that differ significantly between patients and healthy controls. The implicated genes are involved in immune defense and nervous system function, aligning closely with how patients have described their own experience. Lead investigator Chris Ponting described the findings as a wake-up call, noting that genetic variants could "tip the balance" toward developing the disease in susceptible individuals.
The human stakes are staggering. An estimated 67 million people worldwide live with ME/CFS, with no approved treatment, no diagnostic test, and no cure. In the UK alone, the annual economic cost exceeds three billion pounds. For patients, the genetic validation carries meaning beyond the science. Sonya Chowdhury of Action for ME, a co-investigator on the study, noted that many patients have spent years being told their illness was imagined. Co-investigator Andy Devereux-Cooke was more direct: "The vast majority of the patient population has essentially been abandoned," he said — by families, governments, and medicine alike.
Significant questions remain. The study found no genetic explanation for why women are diagnosed four times more often than men, and no shared genetic basis was found between ME/CFS and long Covid despite their symptomatic overlap. Separately, brain imaging research at Oxford detected abnormally high lactate levels in a region tied to effort and emotion, suggesting disrupted energy metabolism — possibly pointing to malfunctioning mitochondria.
The findings do not yet translate into treatments or tests. But they shift the conversation in a way that decades of patient testimony could not. The illness, the data now says plainly, is real. Whether the medical and research communities will finally respond in kind remains the open question.
For decades, people with myalgic encephalomyelitis—the condition known as ME/CFS—have walked into doctors' offices carrying a diagnosis that many in medicine refused to believe was real. They described crushing fatigue, brain fog, sleep that didn't restore them, and a peculiar cruelty: any physical or mental exertion could trigger a collapse that took weeks to recover from. Some were told it was psychological. Some were disbelieved entirely. Now, for the first time, geneticists have found robust biological evidence that the illness is written into human DNA.
Researchers analyzing the world's largest genetic study of ME/CFS have identified eight distinct regions of the human genome that differ significantly between people with the condition and those without it. The DecodeME study, a collaboration between Edinburgh University, patient advocacy groups, and people living with the illness, examined DNA from 27,000 people with ME/CFS and more than 250,000 without it—a dataset of unprecedented scale for this neglected disease. The findings, not yet published in peer-reviewed journals but presented by the research team, suggest that genetic variants scattered across the population raise the risk of developing ME/CFS, though carrying these variants does not guarantee someone will become ill.
Chris Ponting, a lead investigator at Edinburgh, described the results as a wake-up call. Genetics, he said, could "tip the balance" on whether a person develops the disease. The eight regions identified contain genes involved in immune defense and nervous system function—biology that aligns precisely with how patients have described their own experience. Some genetic variants may compromise the body's ability to fight viral and bacterial infections. Others overlap with genetic markers already known to influence chronic pain, a symptom many ME/CFS patients endure. The picture emerging from the data is of a biological condition, not a psychiatric one.
The human stakes are enormous. An estimated 67 million people worldwide have ME/CFS. In the United Kingdom alone, the annual economic cost exceeds three billion pounds. There is no test for the disease, no cure, and no approved treatment. Many patients report that an infection preceded their illness—a viral or bacterial trigger that, in genetically susceptible people, may set off a cascade they cannot reverse. The typical course is devastating: extreme fatigue, cognitive dysfunction, sleep disturbance, and post-exertional malaise so severe that a single day of activity can render someone bedridden for weeks.
For patients, the genetic validation carries weight beyond the science itself. Sonya Chowdhury, chief executive of Action for ME and a co-investigator on DecodeME, spoke directly to this: many people with the condition have been told by doctors that ME is not real, that their illness is imagined or psychological. The genetic evidence provides what patients have long needed—external, objective confirmation that their suffering is rooted in biology. Andy Devereux-Cooke, another co-investigator, was blunt about the abandonment patients have experienced. "The vast majority of the patient population has essentially been abandoned in one way or another, by families, the government, the medical system," he said. This study, he added, is "a welcome drop in the ocean towards turning the tide."
Yet significant mysteries remain unsolved. Women are diagnosed with ME/CFS four times more often than men, but the genetic study found no explanation for this disparity. Researchers also investigated whether long Covid—the prolonged illness some people experience after COVID-19 infection—shares a genetic basis with ME/CFS. Despite symptom overlap, they found no genetic link between the two conditions. Other researchers are pursuing different angles. Beata Godlewska at Oxford used brain imaging to scan people with ME/CFS and long Covid, finding abnormally high levels of lactate in a specific brain region involved in processing effort and emotion. This suggests disrupted energy metabolism in the brain itself, pointing toward malfunctioning mitochondria—the cellular structures that generate energy.
The research opens doors that have been closed for too long. Anne McArdle at the University of Liverpool called the findings "a solid basis" for future work that could accelerate treatment development. Godlewska emphasized what the study might accomplish beyond the science: fighting stigma and convincing research funders that ME/CFS is a truly biological disease deserving of serious investigation and resources. The genetic evidence does not yet provide diagnostic tests or practical treatments. But it shifts the conversation. It says, plainly, that this illness is real. The question now is whether the medical and research communities will finally act accordingly.
Citas Notables
These provide the first robust evidence for genetic contributions to ME. A person's genetics could tip the balance on whether they would develop ME/CFS.— Prof Chris Ponting, University of Edinburgh
The vast majority of the patient population has essentially been abandoned in one way or another, by families, the government, the medical system. This will be huge for the patient population.— Andy Devereux-Cooke, DecodeME co-investigator
La Conversación del Hearth Otra perspectiva de la historia
Why did it take so long for someone to do a genetic study of this scale?
ME/CFS has been systematically neglected. It's not flashy, it doesn't kill people quickly, and for decades the medical establishment dismissed it as psychological. Without that credibility, funding doesn't follow. Without funding, research doesn't happen. The patients themselves had to push for this study.
So the eight genetic regions—do they mean we can now predict who will get ME/CFS?
Not yet. The variants are common in the general population. Many people carry them and never develop the illness. What the study shows is that certain genetic combinations raise risk. It's a predisposition, not a destiny. We still don't understand what the trigger is—why one person with the genes gets sick after a viral infection and another doesn't.
The fact that women are four times more likely to be diagnosed but there's no genetic explanation—what does that tell us?
It suggests something else is at play. Hormones, perhaps. Environmental factors. Or it could be that women are simply more likely to seek diagnosis and be believed when they do. That's a harder thing to measure than DNA, but it matters.
You mentioned long Covid doesn't share a genetic link with ME/CFS, even though the symptoms look similar.
That's striking, actually. It suggests they may be different diseases wearing similar masks. One might be triggered by a persistent viral infection, the other by something else entirely. Or the same trigger produces different outcomes depending on genetics. We don't know yet.
What does this study actually change for someone living with ME/CFS right now?
Immediately? Not much. There's still no cure, no test, no approved treatment. But it changes how they're perceived. It's harder now for a doctor to dismiss them as depressed or deconditioned. It's harder for family members to suggest they just need to push through. The biology is there, in black and white. That matters more than people outside the patient community might realize.
What's the next step?
Understanding what these genes actually do. Why immune and nervous system genes are involved. Whether we can develop a diagnostic test. Whether we can find a drug that addresses the underlying biology. That's years of work. But at least now the work has legitimacy.